Paper830744
Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
Bernstein ID. J Immunol, 1977. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma. Papers, record 830744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/830744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AKR murine leukemia virus | Major topic |
| Immunity, Cellular | Major topic |
| Immunization, Passive | Major topic |
| Lymphoma | Major topic |
| Tumor Virus Infections | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Cells, Cultured | |
| Dose-Response Relationship, Immunologic | |
| Hypersensitivity, Delayed | |
| Immunologic Memory | |
| Immunotherapy | |
| Kinetics | |
| Mitomycins | |
| Rats | |
| Rats, Inbred WF | |
| Sarcoma, Experimental |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29456568 | Harnessing the immune system in the battle against breast cancer. | Drugs Context | 2018 | https://conductscience.org/library/papers/29456568 | PubMed |
| 6984355 | Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6984355 | PubMed |
| 6973429 | Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6973429 | PubMed |
| 6968337 | Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. | J Exp Med | 1980 | https://conductscience.org/library/papers/6968337 | PubMed |
| 3876272 | Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system. | Immunology | 1985 | https://conductscience.org/library/papers/3876272 | PubMed |
| 3876271 | Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1. | Immunology | 1985 | https://conductscience.org/library/papers/3876271 | PubMed |
| 2502309 | Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2502309 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/830744
GET https://conductscience.org/api/papers/v1/830744/authors